TINF2
TINF2[edit | edit source]
TINF2 (TERF1-interacting nuclear factor 2) is a gene that encodes a protein involved in the maintenance of telomeres, which are the protective caps at the ends of chromosomes. The TINF2 protein is a critical component of the shelterin complex, a multi-protein structure that protects telomeres from being recognized as sites of DNA damage and regulates telomere length.
Function[edit | edit source]
The TINF2 protein interacts with other components of the shelterin complex, including TERF1 (telomeric repeat-binding factor 1) and TERF2 (telomeric repeat-binding factor 2). This interaction is essential for the stabilization of telomeres and the prevention of inappropriate DNA repair activities that could lead to chromosomal end-to-end fusions.
TINF2 plays a crucial role in:
- Maintaining telomere integrity and length.
- Protecting chromosome ends from degradation.
- Regulating the access of telomerase, the enzyme responsible for adding telomeric repeats to the ends of chromosomes.
Clinical Significance[edit | edit source]
Mutations in the TINF2 gene have been associated with several human diseases, particularly those related to telomere dysfunction. These include:
- Dyskeratosis congenita, a rare genetic disorder characterized by skin abnormalities, nail dystrophy, and bone marrow failure.
- Revesz syndrome, a severe variant of dyskeratosis congenita, which includes bilateral exudative retinopathy.
- Hoyeraal-Hreidarsson syndrome, a severe form of dyskeratosis congenita with additional neurological and immunological symptoms.
Patients with TINF2 mutations often exhibit very short telomeres, leading to premature cellular senescence and increased susceptibility to age-related diseases.
Research and Developments[edit | edit source]
Ongoing research is focused on understanding the precise molecular mechanisms by which TINF2 mutations lead to telomere dysfunction and associated diseases. Studies are also exploring potential therapeutic strategies to correct or compensate for the effects of TINF2 mutations, such as telomerase activation or gene therapy.
Also see[edit | edit source]
 | This genetics article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
